LA JOLLA PHARMACEUTICAL CO Finite-Lived Intangible Asset, Expected Amortization, Year Five
LA JOLLA PHARMACEUTICAL CO had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $1.60 million as of 2021-12-31, per its 10-K filed 2022-03-09.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2022-03-09
- 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.60M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five |
|---|---|
| 2021-12-31 | $1.60M 10-K · filed 2022-03-09 |